share_log

HC Wainwright & Co. Reiterates Buy on Axsome Therapeuticsto Buy

HC Wainwright & Co. Reiterates Buy on Axsome Therapeuticsto Buy

HC Wainwright & Co. 重申买入Axsome Therapeutics
Benzinga ·  2024/12/31 07:38

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Axsome Therapeutics (NASDAQ:AXSM) from Buy to Buy.

HC Wainwright & Co. 分析师Raghuram Selvaraju将Axsome Therapeutics(纳斯达克:AXSM)从买入重申为买入。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发